Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MethylGene Inc MYLGF

Healthcare Biotechnology

Recent & Breaking News (GREY:MYLGF)

LifeSci Advisors Initiates Coverage of Mirati Therapeutics

Marketwired July 18, 2013

Mirati Therapeutics to Commence Trading on the NASDAQ

Marketwired July 15, 2013

Mirati Therapeutics and MethylGene Announce Completion of Plan of Arrangement

Marketwired June 28, 2013

Mirati Therapeutics and MethylGene Announce Completion of Plan of Arrangement

Marketwired June 28, 2013

MethylGene Shareholders Approve the Plan of Arrangement to Reincorporate in the United States as Mirati Therapeutics Inc.

Marketwired June 25, 2013

MethylGene Shareholders Approve the Plan of Arrangement to Reincorporate in the United States as Mirati Therapeutics Inc.

Marketwired June 25, 2013

MethylGene Presents Clinical Data on Mocetinostat at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting

Marketwired June 3, 2013

MethylGene Presents Clinical Data on Mocetinostat at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting

Marketwired June 3, 2013

MethylGene to Present at the Jefferies 2013 Healthcare Conference

Marketwired May 30, 2013

MethylGene to Present at the Jefferies 2013 Healthcare Conference

Marketwired May 30, 2013

MethylGene to Present Mocetinostat Data at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting

Marketwired May 28, 2013

MethylGene to Present Mocetinostat Data at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting

Marketwired May 28, 2013

MethylGene Reports First Quarter 2013 Financial Results

Marketwired May 13, 2013

MethylGene Reports First Quarter 2013 Financial Results

Marketwired May 13, 2013

MethylGene Announces Plan to Reincorporate in the United States as Mirati Therapeutics, Inc. and List on the NASDAQ

Marketwired May 9, 2013

MethylGene Announces Plan to Reincorporate in the United States as Mirati Therapeutics, Inc. and List on the NASDAQ

Marketwired May 9, 2013

MethylGene Presents Preclinical Data on MG516 at the American Association for Cancer Research Annual Meeting

MarketWire Canada April 8, 2013

MethylGene Presents Preclinical Data on MG516 at the American Association for Cancer Research Annual Meeting

Marketwired April 8, 2013

IIROC Trade Resumption - MYG

Canada NewsWire March 18, 2013

IIROC Trade Resumption - MethylGene Inc.

Newsfile March 18, 2013